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Abstract
Background: The Doloplus-2 is used for behavioural pain assessment in cognitively impaired
patients. Little data exists on the psychometric properties of the Doloplus-2. Our objectives were
to test the criterion validity and inter-rater reliability of the Doloplus-2, and to explore a design for
validations of behavioural pain assessment tools.
Methods: Fifty-one nursing home patients and 22 patients admitted to a geriatric hospital ward
were included. All were cognitively impaired and unable to self-report pain. Each patient was
examined by an expert in pain evaluation and treatment, who rated the pain on a numerical rating
scale. The ratings were based on information from the medical record, reports from nurses and
patients (if possible) about pain during the past 24 hours, and a clinical examination. These ratings
were used as pain criterion. The Doloplus-2 was administered by the attending nurse. Regression
analyses were used to estimate the ability of the Doloplus-2 to explain the expert's ratings. The
inter-rater reliability of the Doloplus-2 was evaluated in 16 patients by comparing the ratings of
two nurses administrating the Doloplus-2.
Results: There was no association between the Doloplus-2 and the expert's pain ratings (R2 =
0.02). There was an association (R2 = 0.54) between the expert's ratings and the Doloplus-2 scores
in a subgroup of 16 patients assessed by a geriatric expert nurse (the most experienced Doloplus-
2 administrator). The inter-rater reliability between the Doloplus-2 administrators assessed by the
intra-class coefficient was 0.77. The pain expert's ratings were compared with ratings of two
independent geriatricians in a sub sample of 15, and were found satisfactory (intra-class correlation
0.74).
Conclusion: It was challenging to conduct such a study in patients with cognitive impairment and
the study has several limitations. The results do not support the validity of the Doloplus-2 in its
present version and they indicate that it demands specific administration skills.
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Background
Pain is common in elderly institutionalized patients, and
prevalence rates ranging from 45% to 84% have been
reported [1,2]. Cognitive impairment is also common in
the same group, and more than 50% of nursing home res-
idents have been found to be cognitively impaired [3,4].
A recent review reported prevalence rates in palliative care
patients ranging from 14% to 44%, rising to 90% prior to
death [5].
Proper pain assessment is a prerequisite for optimal pain
treatment [6], but pain assessment is challenging in cog-
nitively impaired patients. Pain is therefore often over-
looked in these patients [3,7-10], leaving them at risk for
sub-optimal pain treatment [7,11,12]. When feasible, self-
report assessment of pain is regarded as the standard
method [9,13]. In patients with mild to moderate cogni-
tive impairment, studies have reported completion rates
ranging from 47% to 100% for simple self-report tools
such as numerical rating scales and verbal rating scales
[3,10]. Ratings of present pain intensity have the highest
completion rates, while self-report of other pain dimen-
sions, like location, interference and temporal patterns, is
more challenging [10].
Cognitive impairment can make self-report tools for pain
assessment invalid and consequently limits their useful-
ness. Observational assessment of behaviour is an alterna-
tive. While self-report tools primarily assess
communicative pain behaviours that are under the sub-
ject's control, observational tools assess behaviours that
are more unconscious or automatic [14]. Behavioural
assessment tools are therefore appropriate in subjects with
impaired higher mental processes. However, thoroughly
validated tools for behavioural assessment are scarce
[10,15], and several reviewers have noted the lack of vali-
dation of the tools for behavioural pain ratings in the cog-
nitively impaired [2,7,10,15-17]. Although data are
limited, a recent review rated the psychometric aspects of
12 behavioural assessment tools according to several
quality judgement criteria. Five tools (in English versions)
received a satisfactory evaluation of validity and reliability
[17]: the Abbey Scale [18], the Pain Assessment for the
Dementing Elderly (PADE) [19], the Pain Assessment in
Advanced Dementia Scale (PAINAD) [20], the Pain
Assessment Checklist for Seniors With Limited Ability to
Communicate (PACSLAC) [21], and the Doloplus-2 [22].
The review concluded by recommending the PACSLAC
and the Doloplus-2, stating that they seem promising but
required further testing [17].
The Doloplus, launched by Bernard Wary in 1992/93, was
originally a 15-item clinical tool for proxy rating of pain
in elderly patients with cognitive failure [22,23]. It was
based on a tool for behavioural assessment of pain in chil-
dren with neoplastic disease (Douleur Enfant Gustave
Roussy scale) [22,23]. In 1995, the Doloplus was refined
by a French/Swiss network of geriatricians, resulting in the
present ten-item version (Doloplus-2 [22]). A Doloplus-2
assessment is performed by a proxy-rater who observes
the subject and evaluates the presence of ten pain-related
behaviours from 0 to 3 – representing increasing presence
of the behaviour [22,24]. These include: verbal com-
plaints, facial expressions, protective body postures, pro-
tection of sore areas, disturbed sleep, functional
impairment in activities of daily living (washing and
dressing, and general mobility), psychosocial reactions
such as behavioural problems, and changes in communi-
cation or social life. Authors of the Doloplus-2 suggest a
cut-off score of 5 out of 30, representing possible pain
being present [22,23], but this has not been empirically
validated.
Despite a shortage of validation studies published in
international journals and despite a call for thorough val-
idation [25], including information on inter-rater reliabil-
ity [17], the French version of the Doloplus-2 is in
widespread clinical use in France and Switzerland [23].
This prompted us to undertake a Norwegian pilot valida-
tion study in 2004, in which we evaluated 59 patients who
were institutionalized in nursing home units for the
demented [24]. While well established protocols are avail-
able for the validation of self-report based assessment
tools there is no consensus on how to validate tools for
observational assessment. The objective of this pilot study
was to translate the Doloplus-2 from French into Norwe-
gian, to test the translation, explore the user-experiences,
and evaluate the criterion validity of the Doloplus-2. The
aim was to test the Doloplus-2 in patients who were una-
ble to self-report and therefore we compared nurses' Dol-
oplus-2 scores to pain scores (pain criterion) given by
pain experts who examined these patients (R2 = 62%). The
results demonstrated satisfactory criterion validity in
some domains. The Doloplus-2 item for facial expressions
was the most informative, while the item for social life con-
tributed least. All the three items forming the psychosocial
domain (Communication, Social life, and Behavioural
problems) were reported as problematic to conceptualize
and contributed marginally to explain the expert pain
score [24]. These results were supported by a recent study
that evaluated the psychometric properties of the Dolo-
plus-2, and two other tools for behavioural pain assess-
ment, by comparing observer based pain scores from two
independent raters [26]. This study found low congruent
validity in the Doloplus-2, it questioned the validity of the
psychosocial domain, and its clinical usefulness was eval-
uated as moderate by the participating nurses. The authors
acknowledged that the study design was less adequate for
exploring the psychometric properties of the Dololplus-2
compared to the other tools and they requested moreBMC Geriatrics 2007, 7:29 http://www.biomedcentral.com/1471-2318/7/29
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studies on the validity and intra- and inter-reliability of
the Doloplus-2 [26].
Based on the previous results and our experiences with the
use of a pain expert as a criterion for pain, a new study was
launched in order to further study the psychometric per-
formance of the Doloplus-2. The objectives of the present
study were to:
1. Assess the criterion validity of the Doloplus-2 in
patients who are unable to self-report pain due to cogni-
tive failure.
2. Test the inter-rater reliability of a pain expert's ratings
(used as criterion).
3. Evaluate the inter-rater reliability of the Doloplus-2 by
comparing the results from different and independent
administrators.
Methods
Subjects
The subjects were a convenience sample of 73 consecu-
tively recruited patients from two nursing homes (N = 51)
and from the Section of Geriatrics at St. Olav's University
Hospital (N = 22) in Trondheim, Norway. As previous
publications had demonstrated pain to be prevalent in
regular nursing homes and in geriatric hospital units
[3,27], these were approached under the assumption that
painful somatic conditions would be prevalent. The
patients should be unable to self-report pain due to cog-
nitive impairment based upon the nurses' clinical evalua-
tion of the patients. Pain was defined as and limited to
somatic pain, i.e. a symptom generally relieved by analge-
sics, and consequently excluding what the pain expert
interpreted as existential pain.
Baseline characteristics
Cognitive function was assessed by the Mini Mental State
Examination (MMSE) [28,29] administered by either a
ward nurse or a medical student. The MMSE rates the level
of cognitive function on a scale from 0–30. Patients with
scores from 30-21 are regarded as normal to mildly cogni-
tively impaired, scores from 20-11 denote moderate cog-
nitive impairment, and patients scoring 10-0 are severely
cognitively impaired [30]. The MMSE was performed
within the same week as the main data collection. At one
nursing home ward the MMSE was performed within a
month (N = 10). Due to the patients' stabile conditions
this was regarded as appropriate. Ability to perform activ-
ities of daily living (ADL) was evaluated by a nurse famil-
iar with the patient, using the Barthel Index [31]. This tool
describes the ability to perform ADL on a scale from 0–20.
Barthel index scores from 20-15 indicate independence to
mildly disabled ADL function, 14-10 indicate moderate
disability, while a score of 9-0 indicate that the patient is
severely to very severely disabled [32]. The Barthel Index
was completed within a week of the Doloplus-2. The
MMSE and Barthel Index measures were used to provide a
baseline characteristic of the patients' status. Information
regarding patients' use of analgesics was not recorded.
Because our aim was to test if the Doloplus-2 could assess
pain in those who experienced pain, it was not regarded
necessary to know if a low level of pain behaviours were
caused by adequate treatment or lack of pain.
Criterion validity of the Doloplus-2
The Doloplus-2 [22,24] is composed of ten items distrib-
uted on three domains: somatic, psychomotor and psy-
chosocial. The somatic domain has five items, while the
psychomotor and psychosocial domains have two and
three items, respectively. Each item has four response
alternatives, and is scored 0 for normal behaviour,
through to 3 for high levels of pain-related behaviour.
Thus the total Doloplus-2 score ranges from 0–30.
The Doloplus-2 was administered by trained enrolled
nurses, or registered nurses who were familiar with the
patient. The attending daytime nurse completed the Dol-
oplus-2 registration after consulting with the other
personnel who had been involved with the patient during
the past 24 hour period. Pain in the Doloplus-2 was regis-
tered according to the instructions for Doloplus-2 and
recorded once for each patient, usually between noon and
3 p.m. [22].
In line with psychiatric methods for observational assess-
ment and diagnoses in cases where an objective measure
is inaccessible a clinical expert statement was used as the
criterion for pain [33-35]. A pain specialist nurse (pain
expert) from the National Centre of Expertise for Pain and
Complex Disorders at St. Olav's University Hospital of
Trondheim made a single evaluation of each patient's
pain level on an eleven point Numerical Rating Scale
(NRS-11) from zero (no pain) to ten (worst imaginable
pain). Each patient was ascribed two pain intensity scores,
one for pain in movement and one for pain at rest. These
scores were used as the pain criterion. The pain evaluation
was performed the same day as the Doloplus-2 assess-
ment, usually between noon and 4 p.m. The expert's eval-
uation made use of information from the medical record,
reports from nurses and patients (if possible) about pain
during the past 24 hours, and a clinical examination. The
clinical examination comprised observation of the patient
during rest and activity, and examination of common trig-
ger points for pain. Both the expert's pain score and the
nurses' Doloplus-2 scores were based upon the same time
interval and all assessors had access to information about
the patient's medical condition during the past 24 hours.BMC Geriatrics 2007, 7:29 http://www.biomedcentral.com/1471-2318/7/29
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The expert was blinded from the Doloplus-2 administra-
tors' assessment, and vice versa.
As a validation of the evaluations performed by the pain
expert, two geriatricians with expertise in pain presenta-
tion in demented patients observed the pain expert while
he evaluated 15 consecutive patients. Without discussing
the patients with the pain expert, the two geriatricians
independently rated the patients' pain using NRS-11.
Their ratings were later examined for degree of association
with the expert's ratings.
Inter-rater reliability
Inter-rater reliability of the Doloplus-2 was assessed in 16
patients consecutively included at the Section of Geriatrics
at St Olav's University Hospital. A geriatric specialist nurse
(GN) and an enrolled nurse evaluated each patient at the
same day and blinded from each other. The GN assessed
all patients, while a team of six different enrolled nurses
made the second assessment.
See Figure 1 for overview of the study procedure.
Analyses
Univariate regression analyses were performed in order to
analyse how well the Doloplus-2 predicted the expert pain
score (R-squared), and to analyse the contributions of
each of the ten items. Since the Doloplus-2 score maxi-
mizes pain by adding the scores of all items, we chose to
compare with the highest of the pain expert's scores. The
pain-in-movement score was higher than the pain-at-rest
score in all patients and consequently used as the pain
criterion.
Association between the expert's pain ratings and the two
geriatricians' ratings and the inter-rater reliability of the
Doloplus-2 were evaluated with intra-class correlation
coefficients. All analyses were performed by the SPSS sta-
tistical software version 13.0 (SPSS Inc., Chicago, USA).
Ethics
The Regional Committee for Medical Research Ethics
approved the study. As recommended by the committee,
written informed consent was not obtained from the
patients due to their cognitive impairment. Instead, the
patient's nearest relative was informed, both in writing
and orally, and asked to give consent. Eligible patients
were informed orally and asked if they would participate
before the administration of the MMSE and the pain
expert evaluation. Patients were not to be included if they
or their relative declined participation, but no one did.
The constructors of the Doloplus-2 have approved our use
of the tool.
Results
Baseline characteristics
Seventy-three patients were approached and all were
included. The mean age of the sample was 84 years (Table
1), and 74% were female. The median MMSE score was 10
(Table 1). Two subjects died before the MMSE assessment,
and seven were not assessed as they moved to another
nursing home before the MMSE assessment. These
patients were included in the pain analyses, but excluded
from the MMSE calculations. The Barthel Index scores had
a median value of 9 (Table 1).
Study procedure Figure 1
Study procedure. *Performed the same day, usually performed between noon – 3 p.m. **The MMSE and Barthel were per-
formed within the same week as the pain assessments except from ten MMSE that was performed within a month.
51 patients living 
in nursing homes
22 patients from a 
geriatric section at an 
university hospital
MMSE and Barthel**
Doloplus-2 and expert 
evaluation of pain for 
the past 24-hours, 
N=73* Inter-rater reliability in 
16 consecutively 
Doloplus-2 
assessments
Validation of expert in 
15 consecutively pain 
evaluations
Pain assessments Patient samples Tests in sub-samplesBMC Geriatrics 2007, 7:29 http://www.biomedcentral.com/1471-2318/7/29
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Validity of the Doloplus-2
The expert rated seven patients ≥ 4 for pain-in-movement
(moderate-to-severe pain), 40 were rated 1–3, and 26
were rated as without pain. In all patients, the pain-in-
movement score was equal to or higher than the pain-at-
rest score. The association between the pain expert's rat-
ings and the two geriatricians' ratings (N = 15) was esti-
mated with an intra-class correlation of 0.74 with a 95%
confidence interval from 0.5 to 0.89.
The mean Doloplus-2 score was 7.47 (SD = 5.08) with a
range from 0–22. Five patients received a Doloplus-2
score of zero. Among these, three were also rated with no
pain by the expert, while the other two received a score of
zero at rest and two in movement.
The regression analysis of the Doloplus-2 scores against
the expert scores produced an R2  of 0.023, implying
poor criterion validity of the Doloplus-2 in this data set
(Figure 2).
To explore the data more closely we analysed each study
site separately. No significant results were obtained while
looking at the complete data from the three sites; how-
ever, association was found between the pain expert and
the geriatric expert nurse (GN) who administered the Dol-
oplus-2 in 16 patients in the Section of Geriatrics, with an
R2 of 0.54.
Univariate regression analyses of the different Doloplus-2
items (full sample) showed small but significant relation-
ships between the Doloplus-2 item for protective body pos-
tures at rest and the expert's pain-in-movement score (R2 =
0.12, p = 0.003) and for the Doloplus-2 item pain com-
plaints and the expert's pain-at-rest score (R2 = 0.13, p =
0.002).
Inter-rater reliability
The intra-class correlation for inter-rater reliability of the
Doloplus-2 administrators was 0.77, with a 95% confi-
dence interval of 0.47 – 0.92.
Discussion
Herr et al. (2004) called for extensive testing of the Dolo-
plus-2 to provide sufficient details on which to base
sound judgment of the tool, and a recent review ques-
tioned both the specificity of the Doloplus-2 and the
nurses' competence for scoring and interpreting the
results [17]. The present study failed to confirm a valid
relationship between the expert's ratings of pain and the
Doloplus-2 scores in a sample of 73 cognitively impaired
patients, even though the inter-rater reliability of the Dol-
oplus-2 seemed to be satisfactory. These results differ from
those of our previous pilot validation study [24], in which
acceptable criterion validity was demonstrated when com-
paring Doloplus-2 against expert ratings.
We acknowledge several limitations in the present study.
The samples sizes were small as indicated by the confi-
dence intervals for the inter-rater analyses and the major-
ity of the subjects were female (74%). Use of analgesics
was not recorded. Analgesic efficacy might fluctuate
throughout the day and information on the use of analge-
sics could have provided valuable baseline information.
However, since all patients were evaluated on the basis of
the full 24-hour period any potential bias from analgesics
should be equivalent in both the expert and in the Dolo-
plus-2 assessments.
The use of a pain expert's rating as a pain criterion is dis-
putable as it may be questioned whether this represents a
valid criterion. In line with psychiatric methodology for
cases where no obvious gold standard exists, we used an
expert-evaluation of the patients as the pain criterion. We
tested the expert's performance in a sub-sample (N = 15)
and found satisfactory inter-rater reliability between the
expert and the two geriatricians. The low end of the confi-
dence interval for the inter-rater reliability indicates that
despite the small sample size of 15 evaluations the agree-
ment is satisfactory.
It is probably an advantage for an expert-rater to know the
patients. In the pilot study, the physicians responsible for
the patients' treatment acted as the expert [24]. It is possi-
ble that the lack of association between Doloplus-2 and
the expert's rating in the present study may partly be due
to the use of an external pain expert who was unfamiliar
Table 1: Distribution frequencies of background variables
Age (mean 84) Numbers (N = 73)
69–79 years 19 (26%)
80–90 years 37 (51%)
> 90 years 17 (23%)
MMSE-Score (median 10)*
Severely cognitively 
impaired (CI)
0–10 32 (50%)
Moderately CI 11–20 23 (36%)
Mildly CI to normal 21–30 9 (14%)
Barthel Index-Score (median 9)
Very severely to 
severely disabled
0–9 41 (56%)
Moderately disabled 10–14 18 (25%)
Mildly disabled to 
independent in ADL
15–20 14 (19%)
*9-missingBMC Geriatrics 2007, 7:29 http://www.biomedcentral.com/1471-2318/7/29
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with the patients instead of one who was familiar with the
patients and the staff. The expert evaluated the presence of
pain at rest and in movement. The Doloplus-2 does not
distinguish between rest and movement, but adds all
scores together. We decided to use the higher obtained of
the two expert scores. This was without exception the
pain-in-movement score. We do not suggest that the Dol-
oplus-2 is designed to measure only pain in movement,
but we believe that the expert's pain-in-movement score is
the best indicator of pain in these patients.
Five patients were rated with a Doloplus-2 score of zero,
as opposed to 26 in the expert's ratings. In order to discuss
the discrepancy between Doloplus-2 and expert score, the
pain expert, the GN and the Doloplus-2 administrators at
one nursing home were consulted. It was impossible to
know whether the pain expert identified false negative
pain cases or whether the Doloplus-2 identified false pos-
itives. A general conclusion was that Doloplus-2 assess-
ment in many of these patients was perceived as difficult.
In patients who had high Doloplus-2 scores and low
expert scores, clinical examinations revealed that the
patients' discomfort seemed frequently related to grief,
depression, anxiety and/or agitation rather than to
somatic pain. This might suggest that the Doloplus-2
identifies patients with pain who may not have somatic
pain (i.e. false positives), on the other side we can not out
rule that this is a result from the pain expert underrating
pain. The Doloplus-2 administrators were instructed to
give positive scores on items only if changes in behaviour
were suspected to be pain-related. In practice however,
they were not able to evaluate this. As a result, they may
The relationship between expert ratings and Doloplus-2 Figure 2
The relationship between expert ratings and Doloplus-2. The scatter plot demonstrates the relationship between the 
expert's pain score (NRS-11) and the Doloplus-2 score (0–30) in all 73 patients.BMC Geriatrics 2007, 7:29 http://www.biomedcentral.com/1471-2318/7/29
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have given positive scores on behavioural changes proba-
bly related to other causes than pain. This illustrates some
well-known difficulties in pain assessment among
patients with Behavioural and Psychological Symptoms
of Dementia (BPSD) who are not able to describe their
problems thoroughly and who may also have atypical
symptom presentation [17,36]. The expert performed a
comprehensive evaluation of the patient, but his pain rat-
ings focused on what he judged as somatic pain intensity.
The Doloplus-2 approaches pain multidimensional and
this difference can partly explain some of the disagree-
ment between expert and Doloplus-2. A concern for the
validity of the expert judgments could be the use of
patient charts information to inform their judgments. Pre-
sumably, this would allow access to information about
physical pathology. There is only a marginal correlation
between physical pathology and self-report of pain in
people able to self-report. Inferring pain from this infor-
mation can be questionable. However, the pain expert has
several years experience from work at the National Centre
of Expertise for Pain and Complex Disorders at St. Olav's
University Hospital of Trondheim. A majority of the
patients coming to this clinic has pain that does not have
an identifiable basis in physical pathology. In the study
design we wanted to give the expert access to all available
information to minimize the chances of underestimating
pain. He evaluated the different sources of information
towards each other and we are confident in that he did not
underrate pain due to lack of information on physical
pathology in the charts. Instead, it may strengthen
the expert evaluation that the expert was informed about
the patients' diagnoses of possible painful chronic
conditions.
Analyses indicated that competence in geriatrics improved
the validity of the Doloplus-2 assessment. The Doloplus-
2 scores had higher correlations with the expert's pain rat-
ings in a small sub-group in which the Doloplus-2 was
administered by a specialist GN. This finding was in con-
cordance with the pilot study, where the Doloplus-2
administrators had higher skills than the administrators
in the present study, as all assessments were made jointly
by an enrolled nurse/registered nurse in cooperation with
a fully trained final-year medical student [24]. Thus, it
may be hypothesized that valid Doloplus-2 administra-
tion and interpretation demand training in geriatrics and
knowledge of pain presentation in cognitively impaired
patients. Analyses of the sub-group with the GN resulted
in a similar pattern of items contributing in explaining the
expert's pain score to that found in the pilot study [24].
The items for complaints, disturbed sleep, functionality
during washing/dressing, and facial expressions explained
most of the expert score, while the three psychosocial
items explained close to nothing. The Doloplus-2 was
originally developed for pain assessment in children and
the inclusion of the psychosocial items may come from
this origin. Based on results from Zwakhalen et al. (2007)
and our two studies we suggest that the psychosocial
domain could be removed from the Doloplus-2.
Some of the patients could provide limited information
about pain at the moment and this was demonstrated dur-
ing the expert's clinical examination and during the morn-
ing sessions, while the nurses wash and dress the patients,
which caused some patients to express pain complaints,
which then again lead to positive expert pain score and
positive score on the Doloplus-2 item about pain com-
plaints. The subjects' self-report was consequently taken
into account when it was available. Future studies could
try a simple verbal rating scale for self-report of pain
intensity in some patients and use this in a combination
with other criterions.
Reports have shown that pain is frequent, under-recog-
nised and under-treated in nursing homes. Therefore we
approached patients at regular nursing home units and at
a geriatric department in order to include patients with
higher levels of pain than in the pilot study [24]. As
expected the MMSE scores and the Barthel Index demon-
strated that the study population was cognitively impaired
and dependent on care. However, unexpectedly it turned
out that the sample had lower average levels of pain, as
rated by the experts than, the sample in the pilot study.
Low levels of pain have surprised other researchers in the
field [36]. Thus, the present study also failed to provide
data about the performance of Doloplus-2 in patients
with severe pain.
To validate a tool is a long process and solid conclusions
regarding the validity of the Doloplus-2 cannot be
reached on the basis of our two studies. Through our stud-
ies we have established some experience in the design of
studies for such validations. Future studies should include
some patients with known painful diagnoses like patients
with post operative hip-fractures. It will also be most val-
uable to have more than one pain criterion to test for
agreement, in those where self-report is invalid. Pain
experts could be used to establish a criterion. The use of
more than one expert, blinded or unblinded, in each
patient will strengthen the study. Test treatment with anal-
gesics in patients with suspected pain and use of other
behavioural tools and a verbal rating scale for present pain
intensity may be valuable amendments.
The lack of agreement between expert and Doloplus-2
might reflect a common challenge for pain measurement
in cognitively impaired by the use of behavioural assess-
ment tools. Other tools recommended for use in these
patients Abbey Scale [18], PADE [19], PAINAD [20], and
PACSLAC [21] have obvious similarities to the Doloplus-BMC Geriatrics 2007, 7:29 http://www.biomedcentral.com/1471-2318/7/29
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2. All tools cover facial expressions, abnormalities in body
postures/movements like guarding sore areas, impaired
movement and verbal expressions. These tools are con-
structed for administration by health care providers, but
to our knowledge none of them claim any criteria with
regard to the administrators' competence. All tools
include domains that are not only affected by pain. The
inclusion of BPSD increases the pain sensitivity in these
tools, but the specificity decreases. The consequence may
be that comprehensive training of administrators and
high administration skills is needed. The brief Checklist of
Nonverbal Pain Indicators (CNPI) [37] is another inter-
esting behavioural pain assessment tool, as it covers those
parts of the Doloplus-2 that performed most successfully
in our studies, but it needs further validation [17]. The
CNPI may be an alternative that should be thoroughly
tested before finally judged.
Conclusion
Based on the results from our two studies combined, we
recommend the use of more than one pain criterion. Pain
experts can be used as one of these, especially in patients
that have no or limited ability to self-report. A combina-
tion of pain experts, other behavioral pain assessment
tools, a verbal rating scale for self-report of present pain
intensity and test-treatment with analgesics could consti-
tute a promising pain criterion in future studies. The
present study does not support the criterion validity of the
Doloplus-2 as a clinical pain assessment tool in its present
version. The results indicate that there seems to be a need
for systematic training of the administrators before the
instrument can be of clinical use.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
JCH, IS, PMF and SK contributed to the design of this
study. JCH and IS organized and performed the data-col-
lection. JCH, PMF and JHL performed the statistical anal-
ysis. All authors participated in interpretation of the data,
drafting the manuscript and all read and approved the
final manuscript.
Acknowledgements
The authors wish to thank Bjørn Hval, RN, Department of Anaesthesiology, 
St. Olav's Hospital, Trondheim, Norway for his work as the pain expert. 
We also wish to thank the patients and the staff of Trondheim Hospital and 
Ilsvika nursing homes, and The Geriatric Ward at St. Olav's University Hos-
pital for their enthusiastic participation, and Elin Einarson RN, Astri Huseby 
MD, and Silje Songe-Møller medical student, for their invaluable contribu-
tions. This work was financed by The Research Council of Norway.
References
1. Manfredi PL, Breuer B, Meier DE, Libow L: Pain assessment in eld-
erly patients with severe dementia.  J Pain Symptom Manage
2003, 25:48-52.
2. Herr K: Pain assessment in cognitively impaired older adults.
Am J Nurs 2002, 102:65-67.
3. Ferrell BA, Ferrell BR, Rivera L: Pain in cognitively impaired
nursing home patients.  J Pain Symptom Manage 1995, 10:591-598.
4. Matthews FE, Dening T: Prevalence of dementia in institutional
care.  Lancet 2002, 360:225-226.
5. Hjermstad M, Loge JH, Kaasa S: Methods for assessment of cog-
nitive failure and delirium in palliative care patients: implica-
tions for practice and research.  Palliat Med 2004, 18:494-506.
6. Turk DC, Melzack R: Handbook of pain assessment 2nd edition. Lon-
don, Guilford Press; 2001. 
7. Cook AK, Niven CA, Downs MG: Assessing the pain of people
with cognitive impairment.  Int J Geriatr Psychiatry 1999,
14:421-425.
8. Marquie L, Raufaste E, Lauque D, Marine C, Ecoiffier M, Sorum P:
Pain rating by patients and physicians: evidence of system-
atic pain miscalibration.  Pain 2003, 102:289-296.
9. Shannon MM, Ryan MA, D'Agostino N, Brescia FJ: Assessment of
pain in advanced cancer patients.  J Pain Symptom Manage 1995,
10:274-278.
10. Stolee P, Hillier LM, Esbaugh J, Bol N, McKellar L, Gauthier N: Instru-
ments for the assessment of pain in older persons with cog-
nitive impairment.  J Am Geriatr Soc 2005, 53:319-326.
11. Horgas AL, Tsai PF: Analgesic drug prescription and use in cog-
nitively impaired nursing home residents.  Nurs Res 1998,
47:235-242.
12. Scherder E, Oosterman J, Swaab D, Herr K, Ooms M, Ribbe M, Ser-
geant J, Pickering G, Benedetti F: Recent developments in pain in
dementia.  BMJ 2005, 330:461-464.
13. Jensen MP, Karoly P: Self-Report Scales and Procedures for
Assessing Pain in Adults.  In Handbook of Pain Assessment Volume
2. 2nd edition. Edited by: Turk DC and Melzack R. London, Guilford
Press; 2001:15-34. 
14. Hadjistavropoulos T, Craig KD: A theoretical framework for
understanding self-report and observational measures of
pain: a communications model.  Behaviour Research and Therapy
2002, 40:551-570.
15. Herr K, Decker S, Bjoro K: State of the Art Review of Tools for
Assessment of Pain in Nonverbal Older Adults.  2005 [http://
www.cityofhope.org/prc/
Review%20of%20Tools%20for%20Pain%20Assessment/
Review%20of%20Tools%202004/General%20Information/
Project%20Overview.pdf]. The University of Iowa
16. Rodriguez CS: Pain measurement in the elderly: a review.  Pain
Manag Nurs 2001, 2:38-46.
17. Zwakhalen SM, Hamers JP, Huijer Abu-Saad H, Berger MP: Pain in
elderly people with severe dementia: A systematic review of
behavioural pain assessment tools.  BMC Geriatr 2006, 6:3.
18. Abbey J, Piller N, De BA, Esterman A, Parker D, Giles L, Lowcay B:
The Abbey pain scale: a 1-minute numerical indicator for
people with end-stage dementia.  Int J Palliat Nurs 2004, 10:6-13.
19. Villanueva MR, Smith TL, Erickson JS, Lee AC, Singer CM: Pain
Assessment for the Dementing Elderly (PADE): reliability
and validity of a new measure.  J Am Med Dir Assoc 2003, 4:1-8.
20. Warden V, Hurley AC, Volicer L: Development and psychomet-
ric evaluation of the Pain Assessment in Advanced Dementia
(PAINAD) scale.  J Am Med Dir Assoc 2003, 4:9-15.
21. Fuchs-Lacelle S, Hadjistavropoulos T: Development and prelimi-
nary validation of the pain assessment checklist for seniors
with limited ability to communicate (PACSLAC).  Pain Manag
Nurs 2004, 5:37-49.
22. Lefebvre-Chapiro S: The DOLOPLUS 2 scale - evaluating pain
in the elderly.  European Journal Of Palliative Care 2001, 8:191-194.
23. Doloplus C: The Doloplus web-site.  2006 [http://www.dolo
plus.com/versiongb/index.htm].
24. Hølen JC, Saltvedt I, Fayers PM, Bjornnes M, Stenseth G, Hval B, Filbet
M, Loge JH, Kaasa S: The Norwegian doloplus-2, a tool for
behavioural pain assessment: translation and pilot-validation
in nursing home patients with cognitive impairment.  Palliat
Med 2005, 19:411-417.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Geriatrics 2007, 7:29 http://www.biomedcentral.com/1471-2318/7/29
Page 9 of 9
(page number not for citation purposes)
25. Herr K, Decker S, Bjoro K: Doloplus-2.  2004 [http://www.cityof
hope.org/prc/Review%20of%20Tools%20for%20Pain%20Assessment/
Doloplus%20Text.htm].
26. Zwakhalen SM, Hamers JP, Berger MP: The psychometric quality
and clinical usefulness of three pain assessment tools for eld-
erly people with dementia.  Pain 2006, 126:210-220.
27. Cowan DT, Fitzpatrick JM, Roberts JD, While AE, Baldwin J: The
assessment and management of pain among older people in
care homes: current status and future directions.  Int J Nurs
Stud 2003, 40:291-298.
28. Folstein MF, Folstein SE, McHugh PR: Mini-Mental State: a practi-
cal method for grading the cognitive state of patients for the
clinician.  Journal of Psychiatric Research 1975, 12:189-198.
29. Folstein MF, Fetting JH, Lobo A, Niaz U, Capozzoli KD: Cognitive
assessment of cancer patients.  Cancer 1984, 53:2250-2257.
30. Perneczky R, Wagenpfeil S, Komossa K, Grimmer T, Diehl J, Kurz A:
Mapping scores onto stages: mini-mental state examination
and clinical dementia rating.  Am J Geriatr Psychiatry 2006,
14:139-144.
31. Mahoney FI, Barthel DW: Functional evaluation: The Barthel
Index.  Md State Med J 1965, 14:61-65.
32. Wade DT, Hewer RL: Functional abilities after stroke: meas-
urement, natural history and prognosis.  J Neurol Neurosurg Psy-
chiatry 1987, 50:177-182.
33. Kim SY, Caine ED, Currier GW, Leibovici A, Ryan JM: Assessing the
competence of persons with Alzheimer's disease in provid-
ing informed consent for participation in research.  Am J Psy-
chiatry 2001, 158:712-717.
34. Nicholson RA: Validation of a brief form of the Competency
Screening Test.  J Clin Psychol 1988, 44:87-90.
35. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller
E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neu-
ropsychiatric Interview (M.I.N.I.): the development and vali-
dation of a structured diagnostic psychiatric interview for
DSM-IV and ICD-10.  J Clin Psychiatry 1998, 59 Suppl 20:22-33.
36. Leong IY, Chong MS, Gibson SJ: The use of a self-reported pain
measure, a nurse-reported pain measure and the PAINAD
in nursing home residents with moderate and severe demen-
tia: a validation study.  Age Ageing 2006, 35:252-256.
37. Feldt KS: The checklist of nonverbal pain indicators (CNPI).
Pain Manag Nurs 2000, 1:13-21.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2318/7/29/prepub
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral